Xtant Medical Holdings, Inc. (FRA:XMS)

Xtant Medical Holdings Statistics

Total Valuation

FRA:XMS has a market cap or net worth of EUR 82.09 million. The enterprise value is 101.07 million.

Market Cap	82.09M
Enterprise Value	101.07M

Important Dates

The next estimated earnings date is Friday, March 6, 2026.

Earnings Date	Mar 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	140.00M
Shares Outstanding	n/a
Shares Change (YoY)	+11.96%
Shares Change (QoQ)	+1.21%
Owned by Insiders (%)	18.81%
Owned by Institutions (%)	8.34%
Float	45.28M

Valuation Ratios

The trailing PE ratio is 55.00.

PE Ratio	55.00
Forward PE	n/a
PS Ratio	0.72
PB Ratio	1.91
P/TBV Ratio	2.67
P/FCF Ratio	18.62
P/OCF Ratio	12.30
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.84, with an EV/FCF ratio of 22.93.

EV / Earnings	67.73
EV / Sales	0.88
EV / EBITDA	9.84
EV / EBIT	18.53
EV / FCF	22.93

Financial Position

The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.64.

Current Ratio	2.21
Quick Ratio	1.01
Debt / Equity	0.64
Debt / EBITDA	2.72
Debt / FCF	6.28
Interest Coverage	1.55

Financial Efficiency

Return on equity (ROE) is 3.64% and return on invested capital (ROIC) is 4.82%.

Return on Equity (ROE)	3.64%
Return on Assets (ROA)	3.87%
Return on Invested Capital (ROIC)	4.82%
Return on Capital Employed (ROCE)	8.96%
Revenue Per Employee	504,118
Profits Per Employee	6,633
Employee Count	232
Asset Turnover	1.30
Inventory Turnover	1.22

Taxes

In the past 12 months, FRA:XMS has paid 432,968 in taxes.

Income Tax	432,968
Effective Tax Rate	22.49%

Stock Price Statistics

The stock price has increased by +26.06% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+26.06%
50-Day Moving Average	0.61
200-Day Moving Average	0.54
Relative Strength Index (RSI)	47.32
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.26

Income Statement

In the last 12 months, FRA:XMS had revenue of EUR 113.43 million and earned 1.49 million in profits. Earnings per share was 0.01.

Revenue	113.43M
Gross Profit	70.35M
Operating Income	5.41M
Pretax Income	1.93M
Net Income	1.49M
EBITDA	9.29M
EBIT	5.41M
Earnings Per Share (EPS)	0.01

Balance Sheet

The company has 8.86 million in cash and 27.69 million in debt, with a net cash position of -18.82 million.

Cash & Cash Equivalents	8.86M
Total Debt	27.69M
Net Cash	-18.82M
Net Cash Per Share	n/a
Equity (Book Value)	42.94M
Book Value Per Share	0.31
Working Capital	36.50M

Cash Flow

In the last 12 months, operating cash flow was 6.67 million and capital expenditures -2.27 million, giving a free cash flow of 4.41 million.

Operating Cash Flow	6.67M
Capital Expenditures	-2.27M
Free Cash Flow	4.41M
FCF Per Share	n/a

Margins

Gross margin is 62.02%, with operating and profit margins of 4.77% and 1.32%.

Gross Margin	62.02%
Operating Margin	4.77%
Pretax Margin	1.70%
Profit Margin	1.32%
EBITDA Margin	8.19%
EBIT Margin	4.77%
FCF Margin	3.89%

Dividends & Yields

FRA:XMS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.96%
Shareholder Yield	-11.96%
Earnings Yield	1.82%
FCF Yield	5.37%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:XMS has an Altman Z-Score of -0.6 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.6
Piotroski F-Score	8